CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Salvia BioElectronics B.V. developed PRIMUS, a novel peripheral nerve modulator designed to treat chronic cluster headaches and migraines that do not respond to traditional medications. This device uses dual-site stimulation to effectively reduce headache frequency while minimizing side effects, making it a promising s…
Chronic cluster headache and chronic migraine pose a significant challenge for patients and neurologists worldwide.
Approx. 48-64% of the patients experience only limited relief from drug-based treatments, they are drug-refractory.
Salvia BioElectronics B.V. developed PRIMUS, an innovative peripheral nerve modulator to treat exactly these refractory chronic neurovascular headache patients.
The ground-breaking dual-site stimulation targets both the front and back of the head.
In ongoing first-in-…
SALVIA BIOELECTRONICS BV
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
